Dr. Kristina Cortes Alaan, MD

Dr. Alaan practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Alaan's NPI, 1144475419, was assigned on November 30, 2008. Dr. Alaan graduated from American University of the Caribbean School of Medicine in 2008. Dr. Alaan holds Florida license ME169399.

Dr. Alaan's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Alaan's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Alaan to 3 more home health agencies, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alaan practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Alaan's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Alaan is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Alaan's licenses on file in 7 states: Florida, California, West Virginia, Pennsylvania, Virginia, Michigan and Ohio.

Dmand AI lists acute skin infection and joint or bone infection among the conditions Dr. Alaan treats.

CMS data shows 256 Medicare services from Dr. Alaan across 7 procedure codes in 2024, for 139 Medicare patients. Medicare paid $13,961 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Alaan in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alaan's median patient age at 69, with 40% women.

In 2024, Dr. Alaan wrote 372 Medicare Part D claims for 106 patients. 91% of them were for generic drugs. CMS names the drug for 316 of them, across 12 drugs with 11 or more claims each, at $32,764 in total drug cost. In 2023, CMS named 186 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Alaan for performance year 2024, reported through an alternative payment model (APM). Dr. Alaan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 51 procedures of removal of tissue by Dr. Alaan, more than 79% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Alaan.

CMS Open Payments shows 6 general payments to Dr. Alaan from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 88% of the total. LifeNet Health paid the most, $61.

Dr. Alaan graduated from American University of the Caribbean School of Medicine in 2008.

Dr. Alaan is in network with 12 carriers, including Highmark, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.